US 8133894
N-benzyl-4-methyleneamino-3-hydroxy-2-pyridones
granted A61PA61P31/00A61P31/04
Quick answer
US patent 8133894 (N-benzyl-4-methyleneamino-3-hydroxy-2-pyridones) held by Akebia Therapeutics, Inc. expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Akebia Therapeutics, Inc.
- Grant date
- Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P31/00, A61P31/04